Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose safety, pharmacokinetics, and renal potassium clearance study of LY2623091 in healthy volunteers
NL-OMON36630Active, not recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of LY-2623091 in chronic kidney disease (CKD), sponsored by Eli Lilly and Company. Started Oct 2010; status: active, not recruiting.
02
Drugs
LY-2623091
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NL-OMON36630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36630.